Transcription factor (TF) binding specificity is determined via a complex interplay between the TF's DNA binding preference and cell-type specific chromatin environments. The chromatin features that correlate with TF binding in a given cell-type have been well characterized. For instance, the binding sites for a majority of TFs display concurrent chromatin accessibility. However, concurrent chromatin features reflect the binding activities of the TF itself, and thus provide limited insight into how genome-wide TF binding patterns became established in the first place. To understand the determinants of TF binding specificity, we therefore need to examine how newly activated TFs interact with sequence and preexisting chromatin landscapes to determine their binding sites.
Introduction
Sequence-specific transcription factors (TFs) interact with the genome by binding their cognate DNA sequence motifs, using both direct base interactions and DNA structural feature recognition [1] [2] [3] .
However, the presence of cognate motif instances alone is a poor predictor of TF binding 4, 5 . Most TFs bind to only a small fraction of their potential target motif instances in a given cell type, and the cohort of sites which are bound can vary greatly across cell types [6] [7] [8] . These observations suggest that TF binding specificity is constrained by cell-specific chromatin landscapes 7, 9, 10 . For example, cell-specific nucleosome organization and stability can enable or prevent some TFs' access to DNA 5, 11, 12 , whereas certain so-called "pioneer" TFs may be able to override such constraints 12, 13 . Cooperative and antagonistic interactions with other regulatory proteins may also constrain cell-specific TF binding 14, 15 . However, it remains unclear how DNA sequence, chromatin structure, and interactions with other regulators act in concert to determine cell-type specific binding across a range of TFs.
Computational models of genome-wide TF occupancy are often developed with the goal of gaining insight into cell-type specific TF binding mechanisms. Several methods integrate DNA sequence with information about the chromatin landscape in which the TF is binding (i.e. "concurrent" chromatin information) to characterize genome-wide TF binding specificity [16] [17] [18] . However, TFs and their recruited regulatory complexes often alter local chromatin landscapes upon binding to DNA 19, 20 .
Therefore, concurrent chromatin landscapes are not determinants of TF binding but rather parallel measurements of TF binding itself. Models that integrate DNA sequence and concurrent chromatin information can thus only provide limited insights into how a TF's DNA-binding occupancy became established in the first place.
In order to understand the chromatin determinants of in vivo TF binding specificity, we must examine chromatin landscapes that exist in a given cell type prior to TF expression, and then characterize which sites become bound by the TF upon induction. Here, we develop a principled framework to jointly model TF binding as a function of DNA sequence and the preexisting chromatin environment. Specifically, we model genome-wide TF binding through multi-modal deep neural networks that can learn separate representations for the heterogeneous sequence and preexisting chromatin data type modalities, while integrating these distinct representations with readily interpretable deeper layers 21 . Modeling TF binding as a function of both DNA sequence and prior chromatin enables us to estimate the relative contribution of the preexisting cell-type specific chromatin landscape to an induced TF's binding specificity, and allows us to ask whether these contributions differ across TFs.
First, we demonstrate our approach by examining the binding determinants of the pro-neural bHLH TF Ascl1 when it is over-expressed in mouse embryonic stem (mES) cells 22 . Specifically, we characterize the degree to which genome-wide Ascl1 binding depends on the prior mES cell chromatin landscape. We further use our network to examine the DNA sequence and prior chromatin determinants of Ascl1 binding at individual sites, demonstrating that Ascl1 binding occurs across a continuum of sequence and prior chromatin constraints. Second, we expand our analysis to examine the differential sequence and prior chromatin drivers across 12 TFs induced in cell-types in which the prior chromatin accessibility landscape has been characterized (mES cells and NIH-3T3 fibroblast cells) 22, 23 . While we focus here on systems in which TF expression is induced in cell lines, our methods are broadly applicable to study any dynamic regulatory system in which chromatin accessibility landscapes can be assayed before TF binding activity occurs.
Results

A bimodal neural network integrates DNA sequence and prior chromatin accessibility to predict TF-DNA binding
To estimate the dependence of TF binding on the preexisting chromatin accessibility landscape, we use a stepwise forward classification approach. Specifically, we first train a neural network, MS, to predict TF binding using DNA sequence features alone. We then assess whether an expanded network architecture that incorporates sequence and chromatin features, MSC, leads to an improvement in predictive accuracy. Any such improvement points to predictive information in the preexisting chromatin landscape that is not captured by sequence alone.
To model the sequence specificity driving TF binding, we use convolutional neural networks due to their ability to outperform both PWMs and k-mer based string kernels at TF binding prediction tasks 24, 25 . Specifically, our sequence-only network MS uses a convolutional layer followed by a long short-term memory (LSTM) layer and multiple dense layers ( Fig. 1a ). While convolutional filters identify short discriminative PWMs at bound sequences, LSTMs and deeper layers are capable of integrating information from convolutional filters to model higher-order sequence dependencies 18, 24, 26 . We note that in order to test if preexisting chromatin landscapes drive TF binding specificity, we must ensure that our sequence-only model does not learn sequence features associated with the preexisting chromatin accessibility landscape itself. We prevent such features from being learned using careful design of the training mini-batches (see Methods). Methods that model multiple modalities in TF binding predictions tasks often use early-fusion;
i.e. they integrate the modalities into a single input vector 17, 25 . However, low-level correlations between heterogeneous sequence and chromatin accessibility inputs may not always be meaningful or interpretable. To incorporate preexisting chromatin features into our predictive framework, we define a bimodal network architecture that models the sequence and chromatin accessibility through independent sub-networks combined with an additive sigmoidal dense node (Fig. 1b ). DNA sequences from 500bp windows are used as input to the sequence sub-network, whereas binned ATAC-seq and histone mark ChIP-seq data are used as input to the chromatin sub-network (see To test our framework, we focused on characterizing where the bHLH TF Ascl1 binds when expressed in mES cells. Specifically, we trained the networks to predict Ascl1 ChIP-seq data, assayed after 12 hours of ectopic Ascl1 expression in mES cells. We incorporated publicly available ATAC-seq as well as H3K27ac, H3K27me3, H3K4me1/me2/me3, H2A.Z, acH2A.Z, H3K9ac, H3K36me3 and H3K9me3 ChIP-seq data from mES cells as inputs into the chromatin sub-network (see Methods).
Due to the imbalanced nature of the problem, we use the genome-wide area under the precisionrecall curve (auPRC) as a performance metric for both the sequence-only and the bimodal sequencechromatin networks. The precision-recall curves for the sequenceonly model compared to the precision-recall curves for the sequence and prior ES chromatin models. Model performance for held-out chromosome 10 is highlighted in solid yellow and blue lines for illustration; performance for chromosomes 11-14 is represented with lighter (alpha=0.2) traces.
We find that the bimodal sequence and preexisting chromatin model MSC outperforms the sequence-only model MS when trained on induced Ascl1 ChIP-seq data ( Fig. 2a ). While the median auPRC across test chromosomes for the sequence model MS is 0.42, the median auPRC for the joint sequence and preexisting chromatin model Msc is 0.59 ( Fig. 2a ). The improved performance of the Msc model is driven mostly by improved specificity. At a fixed false positive rate (FPR=0.01), a large majority of Ascl1-bound sites are correctly predicted by both models (Suppl. Fig. 1a ). However, at a fixed recall of 80%, the number of false positives predicted by the joint sequence and chromatin network is less than half the number of false positives predicted by the sequence-only network ( Fig.   2b ). As a negative control, a joint sequence and chromatin model trained using a sequenced input Here, 5 is the weight assigned to sub-network , and 5 8 5 6 9 is the non-linear transformation applied by sub-network to input feature vector 5 6 . The bimodal network thus maps each genomic locus to a two-dimensional space defined by the weighted sequence and chromatin sub-network activations.
We make use of the two-dimensional network embedding to examine the sequence and chromatin sub-network activations at individual Ascl1 binding sites. We embed Ascl1-bound genomic regions (orange) as well as randomly sampled unbound genomic regions into the twodimensional network transformed space ( Fig. 3a ). As stated in the previous section, a large majority of Ascl1 binding sites receive high activation scores from the overall MSC network. Interestingly, the high overall scores at Ascl1 binding sites correspond to a broad range of compensatory sequence and chromatin sub-network activations in the two-dimensional embeddings. Ascl1-bound sites with low sequence scores are on average scored highly by the chromatin sub-network. Conversely, bound sites with low chromatin scores are on average scored highly by the sequence sub-network. We quantify this effect using the median sequence score at bound sites (SM) as a threshold to show that the marginal chromatin-score distributions differ at high-scoring ( " 6 > SM) versus low-scoring ( " 6 < SM) Ascl1 binding sites ( Fig. 3b ). Thus, the network learns a model in which Ascl1 binds target sequences that exhibit a broad range of sequence and chromatin sub-network scores, and some degree of compensation between sequence and prior chromatin predicts genome-wide Ascl1 binding.
Figure 3: A)
The contribution of sequence and preexisting chromatin to binding predictions at Ascl1 binding events (orange) and randomly sampled unbound genomic windows (grey). B) Distributions of chromatin subnetwork scores from A) for Ascl1 binding events with sequence scores greater than or less than the median sequence network score.
Motif multiplicity and motif flanks drive variation in sequence sub-network activations at individual Ascl1 binding sites
Next, we aimed to interpret the trained network to identify the sequence and prior chromatin features that drive the observed variation in sequence and chromatin sub-network activations at in vivo TF binding sites. First, we used integrated gradients based feature attribution 27 to confirm that the network learns features associated with Ascl1's cognate E-box binding preference (Suppl. Fig.   2a ,b). Interestingly, we noticed that at many loci, multiple Ascl1 binding E-box motifs were assigned high attribution scores (Suppl. Fig. 2 ), suggesting that motif multiplicity is a predictive feature of Ascl1 binding.
Since gradient-based feature attribution can be susceptible to network parameterizations, we also used an orthogonal strategy to confirm that motif multiplicity defined the high-scoring Ascl1 binding sites. We first calculated the number of Ascl1 cognate E-box motif instances in each 500bp window bound by Ascl1 ( Fig. 4a ). We divided bound loci into categories based on their motif multiplicity, and measured the sequence sub-network activations in each category. Only 5% of all Ascl1-bound loci lack exact matches to the core Ascl1 E-box motif CAGSTG, and these loci were assigned the lowest median scores by the sequence sub-network ( Fig. 4b ). However, a large fraction of Ascl1-bound windows contains more than one exact match to the Ascl1 binding E-box CAGSTG, and the number of motif occurrences is strongly positively correlated with sequence sub-network scores (Fig. 4b ). To systematically examine the relationship between motif multiplicity and sequence sub-network scores, we inserted between one and four randomly spaced motif instances in a set of randomly simulated sequences. We found that the sequence sub-network scores increase with increasing motif multiplicity, indicating that the network indeed uses multiplicity as a feature in predicting Ascl1 binding ( Fig. 4c ). CAGSTG k-mers in simulated sequences
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In addition to the primary motif, motif flanking nucleotides have been shown drive genome-wide Ascl1 binding specificity in mES cells 22 . To test whether the nucleotides flanking the Ascl1 motif CAGSTG affect sequence sub-network activations, we used two complementary simulation strategies.
First, we constructed a single 500 bp reference sequence in which each position is encoded as a [0.25,0.25,0.25,0.25] T vector; i.e. each base [A, T, G, C] T occurs with equal probability at each position along this sequence. We embedded all combinations of the Ascl1 CAGSTG motif flanked by a single nucleotide on either end into this reference sequence, and extracted the sequence sub-network activation at each such simulated sequence. We find large variation in the sequence sub-network output based on the flanking nucleotides, suggesting that the network is learning motif flanking information as a predictor of induced Ascl1 binding ( Fig. 4d ). While certain 8-mers such as GCAGCTGC are scored highly by the sequence sub-network, others such as ACAGCTGCA lead to low sequence sub-network scores. Since an artificially constructed reference baseline may introduce biases into our estimation of sequence activations, we also embed the Ascl1 motif + 1bp flanks into 10,000 randomly generated 500bp sequences, resulting in scores consistent with k-mers embedded into a reference sequence (Suppl. Fig. 3 ). Embedding Ascl1 motifs + 2bp flanks results in a further large variation in scores for each 8-mer (motif +1bp flanks), suggesting that the network learns information beyond 1bp flanking nucleotides (Fig. 4e ). The sequence sub-network thus uses both motif multiplicity and flanking nucleotide information to assign variable sequence scores to in vivo Ascl1 binding sites.
Higher-order chromatin information drives variation in chromatin sub-network activations at individual Ascl1 binding sites
In order to identify the drivers of prior chromatin sub-network activations, we first calculated the distributions of chromatin sub-network activation scores at enrichment domains for each input histone modification ChIP-seq dataset. The median scores for preexisting domains of chromatin accessibility, active histone marks H3K4me1/2/3, H3K27ac, H3K9ac, and active histone variants H2A.Z and acH2A.Z were positive, suggesting that some degree of induced Ascl1 binding is associated with regions that already displayed signs of regulatory activity in the preexisting pluripotent cell state. Conversely, median scores for preexisting H3K9me3 and H4K20me3 domains were strongly negative ( Fig. 5a ), suggesting that the chromatin sub-network uses preexisting repressive/heterochromatic histone modifications as negative predictors of induced Ascl1 binding.
To further examine the determinants of variation in chromatin activations at Ascl1-bound sites, we divided Ascl1 binding sites into quartiles based on their chromatin sub-network activations and calculated their composite tag enrichment profiles for each chromatin track (Fig. 5b ). We found that the genomic windows associated with the highest chromatin sub-network activations were enriched for chromatin accessibility, H3K4me2, H3K4me3 and H3K27ac in the prior cell state. Genomic windows in the second and third quartiles were enriched for H3K4me2 along with H3K4me1 and H2A.Z, but show lower chromatin accessibility, H3K9ac, and H3K27ac. The fourth data quartile, associated with the lowest chromatin sub-network activations, lacked significant enrichment for any histone modifications (Fig. 5b ). To explicitly test for the association of chromatin sub-network activations with particular prior chromatin states, we segmented the genome into twelve states using ChromHMM, and calculated the chromatin sub-network activations at each of these states (Fig. 5c ). We found that preexisting active promoters and strong enhancers were assigned the highest median chromatin scores, followed by weak enhancers and bivalent promoters. regions were assigned the lowest median chromatin scores. Further, consistent with the compensatory behavior observed in the network embeddings, sites where Ascl1 becomes bound in regions associated with mES quiescent and repressed states contain on average higher sequence scores than sites in mES active states (Fig. 5d ).
The preexisting chromatin accessibility is a differential determinant of in vivo TF binding specificity Having examined in depth the ability of the network to characterize the sequence and prior chromatin determinants of TF binding for Ascl1, we next applied our method to compare the differential sequence and prior chromatin drivers across a broader range of TFs. We collected publicly available data for TFs that were induced and profiled via ChIP-seq in cell-types with preassayed chromatin accessibility landscapes (see Methods). Further, to maintain consistency across TFs, we considered only those TFs that were profiled 12 hours post induction, resulting in a dataset comprising of 12 TFs, induced in either mES cells or NIH-3T3 fibroblasts (Suppl. Table 3 ).
We first asked whether incorporation of prior chromatin data improves the ability of a sequenceonly model to predict genome-wide TF binding. We find that the sequence and prior chromatin bimodal network MSC outperforms the sequence-only network MS for all 12 TFs analyzed (Fig. 6a ).
However, we note that the auPRC is susceptible to the imbalance in the data, and thus at a fixed misclassification rate for bound and unbound data, the auPRC will be lower for a TF with fewer binding sites 28 . Thus, as an additional measure for comparison across TFs, we measured the model recall for each TF at a fixed false positive rate (FPR) of 0.01. In addition to reporting the recall, we derived the posterior distribution of the recall for each TF to quantify our degree of belief in our reported recall estimates (see Methods, Fig. 6b ) 29 . Binding models for the TFs Dlx6, Bhlhb8, Six6 and Hlf show greater than 2-fold increases in recall at a fixed FPR, suggesting that the binding of these TFs are highly constrained by the prior chromatin accessibility environment. On the other hand, binding models for Ascl1, Neurog2, Cdx2 and Duxbl show a smaller gain in recall at a fixed FPR on incorporation of prior chromatin accessibility data (Fig. 6b ). We note that the contribution of prior accessibility to the binding of these TFs is not immediately evident in direct comparisons with prior cell type ATAC-seq data, as these TFs bind their target motifs in both pre-accessible and preinaccessible chromatin. As a negative control, we show that using a sequenced input control experiment as input to the chromatin sub-network instead of prior ATAC-seq does not lead to similar gains in model performance for any of the 12 TFs tested. (Suppl. Fig. 4 ). The differential gain in model predictive ability on the incorporation of preexisting chromatin accessibility data suggests that the prior chromatin accessibility landscape differentially constrains in vivo TF binding, and that our framework can identify this differential contribution. Finally, we focused on TFs that can bind target motifs in pre-inaccessible chromatin (TFs for which at least 10% of their binding occurred in pre-inaccessible chromatin), and asked whether the network learns compensatory sequence-chromatin models for these TFs. Specifically, we asked whether the distribution of sequence scores for these TFs was different between pre-accessible versus pre-inaccessible chromatin (Fig. 6c ). We found that the network-assigned sequence scores at pre-inaccessible binding regions were consistently higher than sequence scores at pre-accessible binding regions, compatible with a model that allows certain sequence signatures to override unfavorable chromatin features. In summary, our results show that different degrees of compensation between sequence and prior chromatin landscapes define observed in vivo TF binding specificity, with TFs that bind extensively in pre-inaccessible chromatin showing stronger signatures of compensation.
Discussion
TFs bind subsets of their cognate motif instances in a cell-type specific fashion. Such specificity in TF binding results from an interplay between the TF's inherent sequence preferences and cell-type specific chromatin landscapes 6, 30 . The question naturally arises as to which local chromatin features might enable or inhibit a given TF's binding. However, if we can measure a TF's binding occupancy using ChIP-seq, it has by definition already had its own impact on chromatin in that cell type (e.g. by making its binding sites accessible or by recruiting histone modification enzymes). Concurrent chromatin landscapes therefore predict in vivo TF binding in the same cell type 31, 32 , but cannot be used to model the causal determinants of that binding.
Here, we propose an interpretable neural network architecture, which can be used to assess the relative contribution of DNA sequence and preexisting chromatin features in specifying an induced TF's genome-wide binding sites. We demonstrate our approach on ChIP-seq data for 12 TFs that have been ectopically expressed either in mouse ES cells or NIH-3T3 fibroblasts. Our model suggests that TFs are constrained differentially by the preexisting chromatin accessibility landscape. Predictive models for the TFs such as Dlx6 and Bhlhb8 benefit significantly from the addition of prior chromatin data, suggesting that the binding of these TFs is strongly constrained by cell-type specific chromatin landscapes. On the other hand, predictive models for TFs that bind similar numbers of pre-accessible and pre-inaccessible loci in vivo (Ascl1, Neurog2, Duxbl and Cdx2) gain more limited information upon the addition of prior accessibility information. We note that our estimates of the dependence of TF binding on prior chromatin may still be cell-type specific as opposed to an innate feature of a given TF. For example, while our analyses suggest that binding sites for the pioneer factor Foxa1 is dependent on prior chromatin, this may be specific to the measured context of NIH-3T3 cells. It is possible, for instance, that TFs that cooperate with or otherwise predict Foxa1 binding are already present in NIH-3T3 cells, and Foxa1 may be less dependent on prior chromatin in other cell types.
Related to our work, previous studies have assessed the effects of prior chromatin landscapes on the binding of specific TFs 30, [33] [34] [35] [36] . For example, John et al. showed that Glucocorticoid Receptor (GR) preferentially binds pre-accessible chromatin upon hormone induction 33 . Donaghey et al.
characterized the relationships between the preexisting chromatin landscape and induced FOXA2, GATA4, and OCT4 13 , each of which showed different propensities for binding pre-accessible regions.
Our work aims to provide a unified predictive framework for quantifying and formalizing the relative contributions of sequence and chromatin pre-determinants to TF binding across a range of TFs.
Interpretation of our binding models at individual binding sites suggests that sequence and preexisting chromatin landscapes are not independent predictors of TF binding. Rather, sequence and preexisting chromatin are mutually compensatory features that define a continuum of sites that may be bound by the induced TF. While genomic loci with weaker sequence signatures may be bound by TFs given a favorable local chromatin environment, the same signatures might not be sufficient to drive TF binding at inaccessible or unfavorable chromatin. For example, Ascl1 is more likely to bind pre-inaccessible loci in the presence of certain sequence features such as high motif multiplicity and favorable motif flanks, suggesting that indirect co-operative binding may be a potential mechanism through which Ascl1 binds nucleosomal chromatin 20, 37 .
On the other hand, some highly accessible active promoters and enhancers are bound even with weaker sequence signatures, as defined by low activation scores from the sequence sub-network in our model. We note that some TF-bound regions with high prior chromatin sub-network activations and low sequence sub-network activations might represent artifactual ChIP-seq enrichment 38 .
Alternatively, these regions may represent direct binding to weaker motifs, or indirect binding mediated by interactions with mES or NIH-3T3 cell regulators 39 . While previous studies have proposed sequence-conditional binding to inaccessible chromatin for a few TFs 30, 40, 41 , our work suggests that this compensatory mechanism may exist across a broader range of TFs.
Finally, different TFs are expected to interact differentially with preexisting chromatin landscapes [42] [43] [44] , and the same TF may be more or less dependent on prior chromatin in different cell types. It will therefore be of interest to examine how the relative contributions of sequence and prior chromatin vary in determining the binding of a wider range of TFs, and across a wider array of cell types. Identifying such sequence and chromatin predeterminants of TF binding will be crucial for understanding gene regulation in various dynamic systems such as development and cellular programming.
Methods
ChIP-seq & ATAC-seq data (ES cells):
Generation of the inducible iAscl1 and iNeurog2 mouse ES cell lines and corresponding ChIP-seq data is more completely described in Aydin, et al. 22 . Briefly, inducible cell lines were generated using the inducible cassette exchange (ICE) method as previously described 45 . TF gene constructs are inserted in single copy into the expression-competent HPRT locus. The resulting iAscl1 and iNeurog2 ES cells are differentiated on untreated plates for 2 days to form embryoid bodies, and then expression of the transgene is induced via Doxycycline. Ascl1 and Neurog2 binding was assayed by ChIP-seq 12 hours after Dox induction using the anti-Ascl1 (Abcam, ab74065) and anti-Neurog2 (Santa Cruz, SC-19233) antibodies. We assayed histone modifications as well as chromatin accessibility in EBs with ChIP-seq and ATAC-seq, respectively (Suppl. Data Table   1 ). We collected additional publicly available histone modification and histone variant ChIP-seq datasets from mouse ES cells (Suppl. Data Table 2 ). Together, our dataset defining the chromatin environment of mouse pluripotent cells consists of the following 12 data types: ATAC-seq, H2A.Z, acH2A.Z, H3K27ac, H3K27me3, H3K9me3, H3K4me1, H3K4me2, H3K4me3, H3K9ac, H4K20me3 and
H3K36me3.
ChIP-seq & ATAC-seq data (NIH3T3 cells):
ChIP-seq data for TF inductions in mouse NIH-3T3 fibroblasts was retrieved from Raccaud et al. (GSE119784) 23 . We filtered for TFs that were not expressed as defined by RNA-seq in the NIH3T3 cell line 23 . We used NCIS to estimate the sequenced control-based normalization factors for each TF ChIP-seq experimnent 46 . Further, we filtered out induced TFs that had a multiGPS-reported signal fraction < 0.01 and were single-replicate ChIP-seq experiments (Suppl. Data Table 3 ). We used five ATAC-seq experiments (Suppl. Data Table 4 ) as replicates to construct the network ATAC-seq input 23 .
ChIP-seq & ATAC-seq data processing: Fastq files were aligned to the mouse genome (version mm10) using Bowtie (1.0.1) 47 with options "-q -best -strata -m 1 -chunkmbs 1024". Only uniquely mapped reads were considered for further analysis. MultiGPS (version 0.74) was used to define transcription factor DNA binding events 48 . A q-value cutoff of 0.01 (assessed using binomial tests and
Benjamini-Hochberg multiple hypothesis test correction) was used to call statistically significant binding events with respect to sequenced input material collected from the same cell line. Peakfinding statistics are reported in Suppl. Table 3 . Paired-end ATAC-seq reads were aligned using Bowtie2 (2.2.2) using the "-q -very-sensitive" options 49 . ChromHMM 50 was run using default parameters.
Training and test set construction: For testing, we divided the genome into 500bp non-overlapping windows. For training, we use 500bp overlapping windows, each of which are sequentially offset by 50bp. Genomic windows overlapping peak calls with a p-value ≤ 5x10 -5 are labeled as bound. 
Feature attribution with integrated gradients:
We use integrated gradients to estimate the relative importance of each nucleotide ( 6 ) 6E2 F for each input sequence of length bp. Integrated gradients consider how predictions at input feature vectors differ from reference feature vectors.
More specifically, integrated gradients calculate the gradients at all points along a straight-line path from the reference feature vector to the input feature. In our case, we define a reference feature as a sequence vector such that at each position, each nucleotide is equally likely. In other words, our reference sequence is a 4 * 500 matrix, with each column defined as [0.25, 0.25, 0.25, 0.2s5]. We implemented integrated gradients as defined in Sundarajan et al. 27 .
The posterior distribution of the model recall: We used the model recall at a fixed false positive rate (FPR) to compare model performance across TFs. TPs are true positives in the held-out test set,
whereas FNs are false negatives in the test set.
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However, we note that ChIP-seq signal fractions and the number of peaks called vary widely across TFs. Models trained to predict binding for TF ChIP-seq experiments that contain smaller numbers of peaks (and correlated lower signal fractions) suffer from having access to limited training data. In order to quantify our confidence in the model recall, we use a probabilistic framework that models the recall for each TF given the underlying ChIP-seq data. Specifically, analogous to Brodersen et al. 29 ,
we consider the observed model recall (measured on a single held-out test chromosome) to be an actualization of an underlying true recall value r given N independent Bernoulli trials, where N is the number of binding sites in the held-out test chromosome. Each binding site can be either labeled a true positive (success) or a false negative (failure) by the network.
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We derive the posterior distribution of the recall r assuming a beta (parameters a=1, b=1) prior (for details, see Brodersen et al. 29 ). The mode of this posterior distribution is the observed model recall.
If a TF ChIP-seq experiment contains a small number of peaks, the distribution of r has high variance (e.g. FoxA1, Rhox11, Fig. 6b ). On the other hand, a low variance in the distribution of r reflects a high degree of confidence in our estimate of the recall (e.g. Ascl1, Bhlhb8, Fig. 6b ).
Availability: Open source code (MIT license) is available from https://github.com/seqcode/iTF.
ChIP-seq data have been uploaded to GEO under accession GSE114176.
NIGMS R01GM121613 (to SM), NICHD R01HD079682 (to EOM), and an NVIDIA GPU equipment grant. Supplementary Figure 1: A) The receiver operating characteristic (ROC) curve for the sequenceonly and the joint sequence and prior chromatin models for a classifier trained to predict Ascl1 binding. At a fixed false positive rate (FPR) of 0.05, both models have high true positive rates (TPR > 0.9). B) Model auPRC distributions for held-out chromosomes 10-14. The performance of the additive versus interactive sequence and prior chromatin networks are comparable, confirming that we are not losing predictive ability with a simpler bimodal architecture.
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Supplementary Figure 2: a) & b)
Feature attribution with integrated gradients at two example Ascl1 binding sites (chr10:4710120-4710170 and chr10:28136730-28136800).
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